The abortion industry and its advocates, including two past presidents, have tried to hide the truth about chemical abortion pills.
Working with the Obama administration, in 2015 the FDA no longer required abortionists or others dispensing abortion pills to report any complication, minor or major. The FDA is interested only if the woman dies.
The FDA states on the label of mifepristone (the abortion pill) that only 0.5 percent of women experienced serious adverse reactions. This is based on 10 clinical trials that are over a decade old, involving only 30,966 women.
President Biden jettisoned critical FDA safeguards for women who take chemical abortion pills.
This effectively shielded Danco, the maker of the death drug and the FDA from criticism regarding the drug’s true impact on women.
Until now.
New research reveals that over one in ten women who use chemical abortion pills will experience a serious adverse event. Such as:
- Sepsis
- Infection
- Hemorrhaging
- Transfusion
- Hospitalization
- ER Visit
- Ectopic Pregnancy
- Other life-threatening adverse events
- Required surgical abortion
What do they base these findings on?
Analysts from the Ethics and Public Policy Center studied actual insurance claims of 865,727 women who used chemical abortion between 2017 and 2023. This is the most comprehensive analysis of the safety of chemical abortion in the nation. The results are stunning but not surprising to those who have been fighting for the welfare of women who take these dangerous drugs.
Women are at least 22 times more likely to experience serious complications of chemical abortion pills than the FDA’s label claims.
The research shows that these chemical coat hangers are dangerous for women and kill their unborn babies.
The analysts recommend:
- Require three in-person office visits
- Prescribed only by physicians
- Administered only in an abortion facility, medical office, or hospital
- Assess the gestational age of the baby and rule out ectopic pregnancies
- Physicians must have the skillset to do a surgical abortion when parts of the baby or placenta are left behind – a common complication
- Equipped to provide blood transfusions and resuscitation
- Report all serious complications to the FDA
- Used only during the first seven weeks of pregnancy
These findings should embolden HHS Secretary Robert F Kennedy, Jr. and President Trump to thoroughly investigate the dangers chemical abortion pills present to women and take immediate appropriate action to protect their health and lives.
Defending LIFE,
Brad Mattes,
President, Life Issues Institute
Leave a Reply